Sebastian Dorin Asaftei

8PUBLICATIONS
106CO-AUTHORS
Medical mycologySolid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 24, 2026
Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[18F]FDG PET-Negative Marrow: Results From an International Retrospective Study.

|Mar 25, 2026
Mapping Genomic Heterogeneity in Pediatric and Adolescent-Young Adult Sarcomas: Insights from the Italian SAR-GEN2016 and SAR-GEN_ITA Prospective Multicenter Trials.

Elisa Tirtei, Valeria Difilippo, Federico Divincenzo

|Aug 18, 2025
Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials.

Emanuela Palmerini, Cristina Meazza, Angela Tamburini

|Jul 25, 2025
Tumor Immune Microenvironment-Associated Prognostic and Mifamurtide-Response Gene Signatures for Localized Osteosarcoma: A Correlative Study of the ISG/OS-2 Trial.

Emanuela Palmerini, Maria Rosaria Sapienza, Stefano A Pileri

|Jan 20, 2025
Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial.

Roberto Luksch, Emanuela Palmerini, Giuseppe Maria Milano

|Jul 02, 2021
Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study.

Sebastian Dorin Asaftei, Nadia Puma, Anna Paioli

Pageof 2

Frequent Collaborators

6 joint publications

Emanuela Palmerini

6 joint publications

Franca Fagioli

4 joint publications

Luca Coccoli

4 joint publications

Toni Ibrahim